Our Team

Dara P. Schuster, MD
CEO, T1D Exchange
Dr. Schuster comes to T1D Exchange from Eli Lilly and Company, where she launched the company’s diabetes real-world evidence partnership development program. She has held several leadership roles with Lilly, most recently as Senior Medical Director of Diabetes Medical Affairs for the U.S. and Puerto Rico.

Roy Beck, M.D., Ph.D.
Director, T1D Exchange Clinic Coordinating Center, Executive Director, Jaeb Center for Health Research
Dr. Beck, a physician and epidemiologist, is the director of the Jaeb Center for Health Research in Tampa, FL. In the midst of his more than 25 years’ experience directing and coordinating multi-center clinical trials, type 1 diabetes became a major focus of his research after one of his children developed T1D, starting with the Diabetes Research in Children Network (DirecNet). In addition he has directed the coordinating center for the JDRF Continuous Glucose Monitoring trials and the JDRF Artificial Pancreas Project as well as two type 1 diabetes registries: the Pediatric Diabetes Consortium and the T1D Exchange, funded by the Leona M. and Harry B. Helmsley Charitable Trust. Dr. Beck has been an author or co-author of more than 200 manuscripts in scientific journals. He has been a member of numerous committees of the National Institutes of Health and has served on several journal editorial boards.

Board of Directors

Dana Ball, Co-Founder, T1D Exchange

Abbie Celniker, Ph.D., Partner, Third Rock Ventures

Haydon Keitner, Partner, Nixon Peabody LLP

Jennifer McCabe, Member, Outside GC

Jay Mohr, President, CEO and Co-founder, Dirigo Therapeutics, LLC

Marijane Norris-Geary, President, Yozell Associates

Kim R. Pemble, M.S., CPHIMS, FHIMSS, Vice President, Enterprise Applications and Data Solutions, Marshfield Clinic Health System, University of Minnesota

Deborah Pine, Executive Director, Center for Women and Business, Bentley University

Keith Ryan, President, Geneous Biomedical Advisors, Inc.